![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEirLBTWEoOtAumyNpcbvNGQHFn87AE4nzxZT3mT7L0PKJSDS-L2LkwJo5JgL1wqa_-WEeNMADQ3s2CirlOCB0_j5pzkiFz_ukoOou7t-TrDc6QTY6hs2xvq2WWDvm0Q93G0jGe7GoHpRTer/s1600/rsz_graylogo_copy_2.jpg)
Most of the adverse effects of sotalol can be attributed to its β-blocking activity (e.g., bradycardia, fatigue, dyspnea). The β-blocking effect of sotalol may decrease cardiac contractility. Therefore, this drug should be avoided in patients with HFrEF.
No comments :
Post a Comment